Skip to main content

Table 1 Descriptive statistics of the breast cancer patients by means and standard deviations (SD), n = 56

From: Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer

Characteristics

Mean (min.-max.)

SD

Age at diagnosis, years

55.1 (38–69)

7.89

Education, years

15.8 (8–24)

3.47

Postmenopausal, no (%)

38 (68 %)

 

Systolic BP, mmHg

132 (87–184)

22.9

Diastolic BP, mmHg

77.4 (58–108)

11.9

Height, cm

167 (155–181)

5.97

Weight, kg

70.5 (49–97)

11.6

BMI, kg/m2

25.1 (20.0–33.2)

3.48

Statin use, no (%)

3 (5 %)

 

Serum lipoproteins

 Cholesterol, mmol/L

5.74 (4.00–8.00)

1.00

 HDL-cholesterol, mmol/L

1.78 (1.00–3.00)

0.49

 LDL-cholesterol, mmol/L

3.45 (1.31–5.49)

0.98

 Triglycerides, mmol/L

1.18 (0–3)

0.59

 Apolipoprotein-A, mmol/L

1.67 (1–3)

0.29

 Apolipoprotein-B, mmol/L

1.04 (0–2)

0.27

Tumor characteristics

 Tumor diameter, mm

16.4 (4–40)

8.52

 Grade 1–3

1.96 (1–3)

0.71

 Ki-67 hotspot, %

26.5 (1–81)

21.8

 Nodal metastasis, no

0,75 (0–11)

2.13

 ER positive, no (%)

52 (93 %)

 

 ER percent

88,1 (0–100)

26.9

 PgR positive, no (%)

46 (82 %)

 

 PgR percent

64,2 (0–100)

36.8

 Hormone receptor negative, no (%)

4 (7 %)

 

 HER2 positive, no (%)

3 (5 %)

 
  1. Abbreviations: BP blood pressure, BMI body mass index, ER estrogen receptor, HER2 human epidermal growth factor 2, HDL high-density lipoprotein, LDL low-density lipoprotein, PgR progesterone receptor, Ki 67 antigen Ki-67. ER positive when ≥ 1 %. PgR positive when ≥ 10 %